Destination XL Group Reports Q1 2026 Earnings Call Summary
Destination XL Group reported a -3.8% comparable sales decline for Q1 2026, the best quarterly result in three years due to turnaround initiatives. Management cited structural demand shifts linked to GLP-1 medication usage and increased price sensitivity among consumers.
Topics: GLP-1 impact private brands retail turnaround strategy